Grilled Cheese

ExploreLog inSign up
Terms of UsePrivacy PolicyCommunity StandardsHelpGet the app

Grilled Cheese is a product of Village Compute

Version devBuilt at: 2026-10-10 01:38:52 EDT

Explore

PostsPeople
LatestRanked
@newsen.bsky.socialOct 10, 2026, 8:00 AM

Exploring Kexing Biopharm's Global Impact at CPHI Milan 2026 #None #Milan #Biosimilars #Kexing_Biopharm #CPHI_Milan

@pharmalogsummit.bsky.socialOct 9, 2026, 5:03 AM

The 9th edition of the Global Pharma Logistics Summit (GPLS) takes place on 9 October 2026, bringing industry leaders together to explore the future of pharmaceutical logistics and supply chains.

#GPLS2026 #GlobalPharmaLogisticsSummit #PharmaLogistics #Biopharma #Biosimilars #ColdChain

@newsen.bsky.socialOct 8, 2026, 12:19 PM

Thyme Therapeutics: Revolutionizing Cancer Drug Affordability with Biosimilars #USA #Nashville #oncology #Biosimilars #Thyme_Companies

@newsen.bsky.socialOct 1, 2026, 5:04 AM

Fresenius Finalizes Acquisition of mAbxience to Enhance Biosimilars Portfolio Expansion #Madrid #Germany #Biosimilars #mAbxience #Fresenius

@nikolospharma.bsky.socialSep 23, 2026, 2:53 AM

#TanzaniaPharma #Ustekinumab #Biologics #mAb #PharmaSourcing #CDMO #PharmaAfrica #TanzaniaHealthcare #PharmaImporters #Biosimilars

@pharmazeitung.bsky.socialSep 18, 2026, 1:17 PM

Seit April gilt für #Biosimilars ein verpflichtender Austausch ähnlich den #Generika. Im Gegensatz zu Letztgenannten sind exklusive Rabattverträge bei biologischen Arzneimitteln aber noch verboten. Bei einer Diskussionsrunde in der Pharma-World wurde deutlich, dass das am besten so bleiben sollte.

@4040rec.bsky.socialSep 15, 2026, 9:12 AM

#biosimilars #Sandoz #businessstrategy #pharmanews #Bio100 #biologics #patentprotection #patientaccess #RichardSaymor #ShanghaiHenliusBiotech #genericmedicines #generics #biosimilarpipeline #biosimilardevelopment #biologicmedicines #smallmoleculemedicines
pharmaphorum.com/news/sandoz-...

@pharmaphorum.bsky.socialSep 8, 2026, 2:00 PM

#Sandoz has told #investors that it intends to double its #netsales between 2025 and 2035, and sees a pivot towards #biosimilars as the driving force for that growth.

buff.ly/htHVive